Thrombolysis in ischemic strokes with no arterial occlusion.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4156589)

Published in Int J Stroke on August 01, 2012

Authors

Sourabh A Lahoti1, Louis R Caplan, Gustavo Saposnik, David S Liebeskind, Sankalp Gokhale, Shirish M Hastak

Author Affiliations

1: Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Articles cited by this

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet (1998) 14.00

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37

The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke (1988) 4.22

Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke (2004) 3.19

The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19

Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82

The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke (2011) 1.90

Outcome of acute stroke patients without visible occlusion on early arteriography. Stroke (2004) 1.58

Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Arch Neurol (2002) 1.23

Cerebral miliary aneurysms in hypertension. Am J Pathol (1972) 1.11

Mechanisms in lacunar infarction. Stroke (1992) 1.00

Trends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based study. Stroke (2008) 0.99

Articles by these authors

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81

Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

The PLAN score: a bedside prediction rule for death and severe disability following acute ischemic stroke. Arch Intern Med (2012) 3.26

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18

Diagnosis of acute neurological emergencies in pregnant and post-partum women. Lancet Neurol (2013) 2.98

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80

Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke (2010) 2.77

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76

Dizziness: how do patients describe dizziness and how do emergency physicians use these descriptions for diagnosis? Mayo Clin Proc (2007) 2.75

An uncommon cause of intracerebral hemorrhage in a healthy truck driver. Arch Neurol (2012) 2.61

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50

Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50

Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46

Medical complications after stroke. Lancet Neurol (2010) 2.42

Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36

Delirium in acute stroke: a systematic review and meta-analysis. Stroke (2012) 2.31

Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31

Basilar artery occlusive disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol (2004) 2.30

The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18

Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke (2009) 2.17

Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16

Vertebrobasilar disease. N Engl J Med (2005) 2.06

Higher frequency of atrial fibrillation linked to colder seasons and air temperature on the day of ischemic stroke onset. J Stroke Cerebrovasc Dis (2013) 2.05

Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03

Association between weekend hospital presentation and stroke fatality. Neurology (2010) 2.00

Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke (2013) 1.94

Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology. Stroke (2002) 1.93

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke (2011) 1.92

Pitfalls in the diagnosis of cerebellar infarction. Acad Emerg Med (2007) 1.87

Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol (2008) 1.71

Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71

Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68

Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67

Acute stroke imaging research roadmap. Stroke (2008) 1.66

Is the association of National Institutes of Health Stroke Scale scores and acute magnetic resonance imaging stroke volume equal for patients with right- and left-hemisphere ischemic stroke? Stroke (2002) 1.63

Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation (2005) 1.61

Influence of seizures on stroke outcomes: a large multicenter study. Neurology (2014) 1.60

Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59

Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke (2002) 1.57

Vertebral artery compression of the medulla. Arch Neurol (2006) 1.56

Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol (2002) 1.54

Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54

Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53

Treatment of acute stroke: still struggling. JAMA (2004) 1.52

Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke (2003) 1.51

Dilatative arteriopathy (dolichoectasia): What is known and not known. Ann Neurol (2005) 1.50

Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study. Cerebrovasc Dis (2002) 1.48

Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46

Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke (2007) 1.45

Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43

Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke (2003) 1.43

Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke (2002) 1.42

Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41

Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke (2010) 1.41

The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40

Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40

Now is an exciting time to care for stroke patients. South Med J (2003) 1.40

Teamwork, cooperation, innovation: clues in the Canadian success of stroke care. Can J Neurol Sci (2009) 1.39

Acute cervical internal carotid artery occlusion stroke. JAMA Neurol (2013) 1.39

The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke (2002) 1.31

Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med (2015) 1.29

Vertebrobasilar dilatative arteriopathy (dolichoectasia). Ann N Y Acad Sci (2010) 1.27

Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke (2013) 1.27

Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis (2005) 1.24

A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke (2008) 1.24

Diffusion tensor imaging, white matter lesions, the corpus callosum, and gait in the elderly. Stroke (2009) 1.23

The "double panda sign" in Wilson's disease. Neurology (2003) 1.22

MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20

Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin (2013) 1.20

Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke (2009) 1.18

Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke (2008) 1.18

Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 1.17

Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology (2013) 1.16

Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke (2009) 1.15

Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14

FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med (2004) 1.11

Spontaneous intracranial internal carotid artery dissection: report of 10 patients. Arch Neurol (2002) 1.10

Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09

Clarifying differences among thrombolysis in cerebral infarction scale variants: is the artery half open or half closed? Stroke (2013) 1.09

Acute unilateral hearing loss as an early symptom of lateral cerebral sinus venous thrombosis. JAMA Neurol (2013) 1.08

Quality of ischemic stroke care in emerging countries: the Argentinian National Stroke Registry (ReNACer). Stroke (2008) 1.08

Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke (2010) 1.08

Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke (2011) 1.08

Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke (2013) 1.07

Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy. Neuropsychiatr Dis Treat (2013) 1.06

Clinical assessment of noninvasive intracranial pressure absolute value measurement method. Neurology (2013) 1.06

Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke (2010) 1.06

Cell therapy for stroke. NeuroRx (2004) 1.06

Collateral lessons from recent acute ischemic stroke trials. Neurol Res (2014) 1.05

Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 1 - rationale and general methods. Int J Stroke (2014) 1.05

Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry. Arch Neurol (2011) 1.04

Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab (2012) 1.03